FDA approves new, cheaper rival to EpiPen allergy shot

[rangerrebew]

FDA approves new, cheaper rival to EpiPen allergy shot
June 16, 2017 by Linda A. Johnson
 

U.S. regulators have approved new competition for EpiPen, the emergency allergy medicine that made Mylan a poster child for pharmaceutical company greed.

The Food and Drug Administration on Thursday approved Adamis Pharmaceuticals Corp.'s product, which should go on sale later this year.

Symjepi is a syringe prefilled with the hormone epinephrine, which helps stop life-threatening allergic reactions from insect stings and bites, foods such as nuts and eggs, or certain medications.


Read more at: https://medicalxpress.com/news/2017-06-fda-cheaper-rival-epipen-allergy.html#jCp

[Applewood]

Good.   

And I hope Mylan chokes on their ill-gotten profits. 

[catfish1957]

Good.   

And I hope Mylan chokes on their ill-gotten profits.

Mylan in the past year provided a textbook example of a PR disaster.  Might as well had Ron Burgundy as corporate spokesman.

[Wingnut]

If the steps for delivery of the drug is the same as with the "Epipen" We will request the Symjepi alternative. 

Die Mylar die.

[Frank Cannon]

Let me know when they offer one of these pens with Heroin.

[Polly Ticks]

Meanwhile, it appears that Mylan has introduced their own generic version of the EpiPen:

[attachment deleted by admin]

[catfish1957]

Meanwhile, it appears that Mylan has introduced their own generic version of the EpiPen:

At near the  same time the FDA approves alternative vendors........   How convenient.

[Applewood]

Meanwhile, it appears that Mylan has introduced their own generic version of the EpiPen:

There is competition out there, but doctors may not know about the alternatives,  or they may be receiving some compensation from Mylan, so they will prescribe Epi Pen routinely.  Or the alternatives are not covered by insurance.  Honestly, I think Mylan has tried to downplay and stifle the competition, so only their product will appear to be the only alternative.  Certainly, it seems that the company has the lock on advertising.  Have you seen other such pens advertised?  I don't recall ever seeing a commercial or print ad for any ofbthem. So most people don't even know alternatives are out there.  My hope is that this new, cheaper product will blow Mylan out of the water and kill off this virtual monopoly.  Certainly, the insurance companies, always on the lookout for the cheaper medicines will embrace this newer, less expensive product, so insurance won't be a problem. Gives the patient a choice.

[Drago]

Generic epinephrine auto-injection pens have been around for years:

http://adrenaclick.com

http://epinephrineautoinject.com/what_is_epinephrine_injection_USP_auto_injector.php